InCrowd, provider of real-time market intelligence to life sciences firms, announced that after closing a strong Q2 2015 it has named longtime healthcare business development executive Art McKee as vice president of strategic alliances, effective today.
McKee’s appointment caps a quarter where InCrowd signed the 19th member of the Global Top 20 pharmaceutical firms list as its customer – while posting 100% year over year growth in revenues over the past 3 years,.. At InCrowd McKee will focus on expanding sales at major accounts and establishing new market opportunities for the company’s cloud-based on-demand verified insights.
“Art McKee is exactly the sales leader we need to accelerate our ability to land and expand at corporate accounts,” said Mark Antonacci, executive vice president of sales at InCrowd. “His knowledge of the life science space is deep, and his diligence in delivering innovative solutions to his clients is unmatched. We’re delighted to welcome him to our team.”
Art McKee joins InCrowd after more than 20 years of business development experience at technology and market research companies serving the pharmaceutical and biotech industry. Most recently he was president of Instar Research, where he led all aspects of the US business unit including client management and strategic consulting activities . He also served as global vice president of strategic account development at analytics firm Affinnova of Waltham MA and held senior sales management roles at Healogix, Double Helix, Ziment, TNS Intersearch, Genactis, and did market research and forecasting for Wyeth-Lederle Vaccines. He has been a guest lecturer at Rutgers University’s Pharmaceutical MBC program and holds an MBA from LaSalle University and a BA from Rider University.
About InCrowd
InCrowd provides real-time market intelligence from validated experts, connecting life sciences companies directly with prescribers, patients, and other screened and validated healthcare professionals around the globe. Our easy-to-use proprietary web-based application allows clients to ask questions of specific respondent groups – “Crowds” – in the form of 2-5 minute online microsurveys. Responses are available in real time through a password-protected account, with the needed answers delivered within hours or days, not weeks and months.
Today, InCrowd has 19 of the top 20 pharmaceutical firms as customers and has just finished its most successful quarter in company history with a record number of answers delivered to clients. Through its powerful mobile microsurvey methodology and analytics engine, InCrowd enables clients to reach 1.8M healthcare professionals on-demand throughout the United States and around the globe in 20 languages. For more information, visit www.incrowdnow.com.
